Meloxicam G.L.

Meloxicam, the active ingredient in Meloxicam G.L., is a nonsteroidal anti-inflammatory drug (NSAID) presented as a strength/form for oral use. It treats osteoarthritis, rheumatoid arthritis and acute musculoskeletal pain in adults.

GNH USA supplies Meloxicam G.L. as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal conditions.

Osteoarthritis: alleviates joint pain and improves mobility. Rheumatoid arthritis: decreases synovial inflammation and joint swelling. Acute musculoskeletal pain: provides rapid analgesic relief for sprains, strains and other soft‑tissue injuries.

Meloxicam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Abdominal discomfort - Headache - Dizziness - Skin rash

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding - Elevated liver enzymes or hepatitis - Severe skin reactions such as Stevens‑Johnson syndrome - Acute renal impairment or failure - Cardiovascular thrombotic events - Anaphylactic reaction

Before prescribing meloxicam, clinicians should consider several safety factors.

Assess gastrointestinal risk: evaluate history of ulcers or bleeding. Monitor blood pressure: NSAIDs can raise systolic and diastolic values. Evaluate renal function: check creatinine clearance in at‑risk patients. Use lowest effective dose: limit exposure to the minimum necessary duration. Avoid in known hypersensitivity: discontinue if allergic reactions occur. Store at room temperature: keep in the original pack, protect from moisture.

Meloxicam can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - ACE inhibitors or ARBs: heightened chance of renal dysfunction. - Lithium: elevated serum lithium levels.

Moderate Interactions (Monitor Closely):\n- Other NSAIDs: additive gastrointestinal toxicity. - Diuretics: possible reduction in renal clearance. - SSRIs or SNRIs: enhanced bleeding tendency.